Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials (2107)
Turner I, Buse D, Blumenfeld A, Stock E, Stock D, Conway C, Jensen C, Morris B, Coric V, Croop R. Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials (2107). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.2107.Peer-Reviewed Original ResearchNonsteroidal anti-inflammatory drugsPhase 3 trialAnti-inflammatory drugsPost Hoc AnalysisHoc Analysis